T1	Participants 34 142	T cell subpopulations, NK activity, humoral immunity and leukocyte count in patients undergoing chemotherapy
T2	Participants 204 334	T cell subpopulations, natural killer cell (NK) activity, humoral immunity and leukocyte count in patients undergoing chemotherapy
T3	Participants 378 410	patients undergoing chemotherapy
T4	Participants 793 859	Patients undergoing chemotherapy combined with electro-acupuncture
T5	Participants 1081 1135	auxiliary therapy for patients undergoing chemotherapy
